Ad is loading...
ASPHF
Price
$2.69
Change
-$0.00 (-0.00%)
Updated
May 13 closing price
SPHRF
Price
$0.08
Change
-$0.00 (-0.00%)
Updated
Nov 18 closing price
Ad is loading...

ASPHF vs SPHRF

Header iconASPHF vs SPHRF Comparison
Open Charts ASPHF vs SPHRFBanner chart's image
ASCENTAGE PHARMA GROUP
Price$2.69
Change-$0.00 (-0.00%)
Volume$1K
CapitalizationN/A
Starpharma Holdings
Price$0.08
Change-$0.00 (-0.00%)
Volume$100
CapitalizationN/A
ASPHF vs SPHRF Comparison Chart
Loading...
View a ticker or compare two or three
VS
ASPHF vs. SPHRF commentary
Nov 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASPHF is a Buy and SPHRF is a Buy.

COMPARISON
Comparison
Nov 25, 2024
Stock price -- (ASPHF: $2.69 vs. SPHRF: $0.08)
Brand notoriety: ASPHF and SPHRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASPHF: 100% vs. SPHRF: 1%
Market capitalization -- ASPHF: $1.66B vs. SPHRF: $31.3M
ASPHF [@Biotechnology] is valued at $1.66B. SPHRF’s [@Biotechnology] market capitalization is $31.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $468.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASPHF’s FA Score shows that 0 FA rating(s) are green whileSPHRF’s FA Score has 1 green FA rating(s).

  • ASPHF’s FA Score: 0 green, 5 red.
  • SPHRF’s FA Score: 1 green, 4 red.
According to our system of comparison, SPHRF is a better buy in the long-term than ASPHF.

Price Growth

ASPHF (@Biotechnology) experienced а 0.00% price change this week, while SPHRF (@Biotechnology) price change was +20.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
ASPHF($1.66B) has a higher market cap than SPHRF($31.3M). ASPHF YTD gains are higher at: -16.199 vs. SPHRF (-29.799).
ASPHFSPHRFASPHF / SPHRF
Capitalization1.66B31.3M5,291%
EBITDAN/AN/A-
Gain YTD-16.199-29.79954%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
SPHRF: Fundamental Ratings
SPHRF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FYX108.791.67
+1.56%
First Trust Small Cap Core AlphaDEX® ETF
PSP70.930.58
+0.82%
Invesco Global Listed Private Equity ETF
MUSQ23.990.14
+0.58%
MUSQ Global Music Industry ETF
ISRA42.250.14
+0.32%
VanEck Israel ETF
VMBS45.770.11
+0.24%
Vanguard Mortgage-Backed Secs ETF

ASPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASPHF has been loosely correlated with CGEN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ASPHF jumps, then CGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASPHF
1D Price
Change %
ASPHF100%
N/A
CGEN - ASPHF
41%
Loosely correlated
-2.76%
CLLS - ASPHF
34%
Loosely correlated
+0.54%
CMVLF - ASPHF
34%
Loosely correlated
N/A
NURPF - ASPHF
30%
Poorly correlated
-9.14%
ALDX - ASPHF
27%
Poorly correlated
+0.83%
More

SPHRF and

Correlation & Price change

A.I.dvisor tells us that SPHRF and CGEN have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SPHRF and CGEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHRF
1D Price
Change %
SPHRF100%
N/A
CGEN - SPHRF
26%
Poorly correlated
-2.76%
SPHRY - SPHRF
25%
Poorly correlated
N/A
NURPF - SPHRF
23%
Poorly correlated
-9.14%
SOLTF - SPHRF
23%
Poorly correlated
N/A
ASPHF - SPHRF
22%
Poorly correlated
N/A
More